共1页/18条首页上一页1下一页尾页
回复:18 阅读:9515
免疫组化鉴别乳腺导管浸润癌和小叶癌

yang 离线

帖子:304
粉蓝豆:21
经验:344
注册时间:2006-09-26
加关注  |  发消息
楼主 发表于 2007-01-15 12:58|举报|关注(0)
浏览排序[ 顺序 逆序 楼主 支持 精彩 ]  快捷回复
祝贺网站恢复。

免疫染色                              乳腺导管性肿瘤              乳腺小叶性肿瘤       
统计                               %阳性        总例数          %阳性        总例数
Catenin-β                        100            10               0           22
Cytokeratin(HMW)-34BE12          0            20              100           40
E-Cadherin                       100          568              4           321
标签:
本帖最后由 于 2007-01-19 14:14:00 编辑
0
添加参考诊断
×参考诊断
  

shihuaiy 离线

帖子:707
粉蓝豆:35
经验:707
注册时间:2006-09-27
加关注  |  发消息
1 楼    发表于2007-04-28 17:41:00举报|引用
返回顶部 | 快捷回复
 一直再用这些抗体做二者的鉴别。至于少数E-cad阳性的小叶癌,不知是否有导管癌伴小叶癌化(cancerization)的问题。
0
回复
signature
the more we discuss, the more we learn from each other !!

mjma 离线

帖子:703
粉蓝豆:24
经验:789
注册时间:2006-09-28
加关注  |  发消息
2 楼    发表于2007-04-28 19:15:00举报|引用
返回顶部 | 快捷回复
Histology of some ductal carcinomas mimics lobular carcinomas, and this is observed at both in situ and invasive cases. The most useful marker to differentiate ductal from lobular differentiation remains E=Cadherin. Very rare cases of lobular carcinoma (in situ and invasive) will express strong E-Cadherin on immunohistochemistry. As for 34betaE12, it is not as consistent as some have claimed. In other words, some ductal carcinomas have strong expression of this marker just like lobular carcinomas do. My experience with beta-catenin is limited.
0
回复
signature

聞道有先後,術業有專攻

wangzhen_01 离线

帖子:197
粉蓝豆:3
经验:197
注册时间:2006-10-04
加关注  |  发消息
3 楼    发表于2007-04-28 23:57:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2007-04-29 12:03:00 编辑

马老师发言翻译:
 一些导管癌的组织学与小叶癌很相似,这在一些原位导管癌和侵袭性导管癌病例中都可以观察到。E-Cadherin是一个鉴别导管癌向小叶分化的有用的标志。免疫组织化学检测E-Cadherin 蛋白,小叶癌(原位的或者侵袭性的)呈强阳性的很少。至于34betaE12,它并不像某些人说的那样一致,有些导管癌中34betaE12呈现和小叶癌中一致的强表达。而beta-catenin,我还没有什么经验。

0
回复
signature
吾表兄,年四十余。始从文,连考三年而不中。遂习武,练武场上发一矢,中鼓吏,逐之出。改学医,自撰一良方,服之,卒。

knight 离线

帖子:59
粉蓝豆:2
经验:59
注册时间:2007-04-01
加关注  |  发消息
4 楼    发表于2007-04-29 12:03:00举报|引用
返回顶部 | 快捷回复

翻译并学习马老师的发言:

 在导管原位癌和浸润癌的病例中均可看到某些导管癌模仿小叶癌的组织学特点。区别导管和小叶分化的最有用的抗体是E-Cadherin。极少有小叶管癌(原位的和浸润的)会有E-Cadherin 的强表达。至于34betaE12,它和某些人声称那样并不一致。换言之,某些导管癌和小叶癌一样,有这个抗体的强表达。我对于beta-catenin 的经验有限。

0
回复

wangzhen_01 离线

帖子:197
粉蓝豆:3
经验:197
注册时间:2006-10-04
加关注  |  发消息
5 楼    发表于2007-04-29 12:06:00举报|引用
返回顶部 | 快捷回复

 谢谢knight,我是随便翻译的,对不起,应该abin有个分工的,免得劳动重复,呵呵。

0
回复
signature
吾表兄,年四十余。始从文,连考三年而不中。遂习武,练武场上发一矢,中鼓吏,逐之出。改学医,自撰一良方,服之,卒。

knight 离线

帖子:59
粉蓝豆:2
经验:59
注册时间:2007-04-01
加关注  |  发消息
6 楼    发表于2007-04-29 12:12:00举报|引用
返回顶部 | 快捷回复
 不要这么客气。我不知道你已经翻译过了。大家一起学习,我也是在练习。Abin指定的人没来,我先抛砖引玉他应该不会生气的。呵呵。
0
回复

liuhuiwq 离线

帖子:51
粉蓝豆:1
经验:51
注册时间:2009-08-23
加关注  |  发消息
7 楼    发表于2009-11-15 22:00:00举报|引用
返回顶部 | 快捷回复
 学习了
0
回复

abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息
8 楼    发表于2007-04-29 13:16:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2007-04-29 13:20:00 编辑  

可能小白, 猪猪和 女巫最近忙没有上网看到翻译任务。毕竟大家都有忙的时候,都可能需要别的朋友援助。非常感谢wangzhen_01和knight及时帮助他们完成。朋友们能互相合作,分工不分家,我非常开心。再次感谢!

楼上两位发表的时间只有几分钟之差,呵呵,可能发表时都看不到对方已经发表了。而且,我分工不明,检讨。

0
回复
signature

华夏病理/粉蓝医疗

为基层医院病理科提供全面解决方案,

努力让人人享有便捷准确可靠的病理诊断服务。


yang 离线

帖子:304
粉蓝豆:21
经验:344
注册时间:2006-09-26
加关注  |  发消息
9 楼    发表于2007-05-29 09:58:00举报|引用
返回顶部 | 快捷回复
 最近美国外科病理学杂志[American Journal of Surgical Pathology. 31(3):427-437, March 2007)],:Lobular Versus Ductal Breast Neoplasms: The Diagnostic Utility of P120 Catenin.
但是只能看摘要,无法看全文。
0
回复

wangzhen_01 离线

帖子:197
粉蓝豆:3
经验:197
注册时间:2006-10-04
加关注  |  发消息
10 楼    发表于2007-05-29 19:59:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2007-05-31 18:01:00 编辑  

文章还可以,我放在huaxiapathology@yahoo.com.cn。供大家参考。

0
回复
signature
吾表兄,年四十余。始从文,连考三年而不中。遂习武,练武场上发一矢,中鼓吏,逐之出。改学医,自撰一良方,服之,卒。

yang 离线

帖子:304
粉蓝豆:21
经验:344
注册时间:2006-09-26
加关注  |  发消息
11 楼    发表于2007-05-31 10:46:00举报|引用
返回顶部 | 快捷回复
收到wangzhen_01 老师发来的文献,在此特表感谢。
0
回复

abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息
12 楼    发表于2007-05-31 18:35:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2007-05-31 18:55:00 编辑   感谢yang老师提供信息,感谢wangzhen_01查阅原文。


Lobular Versus Ductal Breast Neoplasms

The Diagnostic Utility of P120 Catenin

Abstract: The distinction between lobular and ductal lesions of the breast is important in several circumstances.
Diagnostic reproducibility of lobular versus ductal lesions, based on histology alone, is less than optimal. The
proper distinction between atypical lobular hyperplasia, lobular carcinoma in situ and low-grade ductal carcinoma
in situ is critical for patient management. Patients who have a core biopsy of invasive lobular carcinoma often
have preoperative magnetic resonance imaging to prepare the surgeon for proper margin attainment. E-cadherin, a
negative membrane marker for lobular neoplasia, is useful in the distinction of lobular versus ductal neoplasia,
but as a negative marker, can be difficult to interpret in particularly challenging cases. In this study, we
surveyed primary and metastatic ductal lesions (62) and lobular lesions (64) of the breast to determine if P120
catenin is useful in the diagnostic distinction between lobular and ductal neoplasia. Primary breast ductal and
lobular preneoplastic and neoplastic lesions were immunostained with E-cadherin and P120ctn and independently
classified as ductal or lobular lesions. In addition, a wide array of carcinomas of different types were surveyed
with P120ctn in tissue microarrays to ascertain whether the cytoplasmic P120ctn immunostaining pattern observed in
lobular neoplasia was unique. Accurate categorization of ductal versus lobular neoplasia in the breast with
P120ctn immunostaining was effective in all cases. Separation of low-grade ductal carcinoma in situ from lobular
neoplasia was efficient. Diagnostically, P120ctn was particularly useful in identifying early lesions of lobular
neoplasia. Of the other tumors that may morphologically mimic lobular carcinoma, only the diffusely infiltrating
variants of rectal and gastric carcinomas showed diffuse cytoplasmic P120ctn immunostaining. Caution should be
exercised when examining tumors in metastatic sites with P120ctn, with the incorporation of an appropriate panel
of immunostains. 

FIGURE 1. Lobular versus ductal neoplasia.
A, Invasive lobular carcinoma, hematoxylin/eosin.
B, P120ctn: invasive lobular carcinoma with diffuse cytoplasmic stain.
C, Comparison of membranous P120ctn staining in normal duct to the cytoplasmiconly staining of lobular carcinoma.
D, Negative E-cadherin of the same case in (C), membranous pattern in normal duct.
FIGURE 2. A to J, P120 ctn in challenging diagnostic cases:
A and B, duct epithelial hyperplasia or emerging lobular neoplasia (ALH)?
C, P120ctn shows intense cytoplasmic immunostaining of ALH cells appearing in the lobule; compare with the left side
of the photograph where P120ctn shows membranous immunostaining of the terminal lobule cells.
D, Higher magnification of lobular neoplasia (ALH) in 2C.
E, E-cadherin result of this same case is less conspicuous, but shows lack of membrane immunostaining of ALH cells.
Myoepithelial cells are stained with E-cadherin.
F, Shows immunostaining of myoepithelial cells with smooth muscle myosin heavy chain in the section
adjacent to (E).
G, Low-grade ductal neoplasia, or lobular neoplasia with microcalcification?
H, P120ctn confirms lobular neoplasia with characteristic intense, diffuse cytoplasmic immunostaining.
I, This area of LCIS lacks E-cadherin stain but shows myoepithelial cell staining, which some may find confusing.
J, Same area as (H) which intensely displays P120ctn characteristic for LCIS.
FIGURE 3. A, Pleomorphic variant of lobular carcinoma, hematoxylin/eosin.
B, Diffuse cytoplasmic pattern for P120ctn.
0
回复
signature

华夏病理/粉蓝医疗

为基层医院病理科提供全面解决方案,

努力让人人享有便捷准确可靠的病理诊断服务。


abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息
13 楼    发表于2007-05-31 19:03:00举报|引用
返回顶部 | 快捷回复
 
  • 图1
  • 图2
  • 图3
0
回复
signature

华夏病理/粉蓝医疗

为基层医院病理科提供全面解决方案,

努力让人人享有便捷准确可靠的病理诊断服务。


hongpinguo 离线

帖子:92
粉蓝豆:142
经验:109
注册时间:2009-01-16
加关注  |  发消息
14 楼    发表于2009-08-12 21:01:00举报|引用
返回顶部 | 快捷回复
 学习了,谢谢
0
回复
signature
韩绘宇

yang 离线

帖子:304
粉蓝豆:21
经验:344
注册时间:2006-09-26
加关注  |  发消息
15 楼    发表于2009-08-12 22:31:00举报|引用
返回顶部 | 快捷回复

 我近来用组织芯片回顾了153例乳腺癌,发现P120Catenin和E-Catenin在乳腺小叶癌和导管癌的鉴别上特异性很好,CK(high)-34βE12特异性不高。过一段时间我把照片和结果上传。

0
回复

abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息

shanghainese 离线

帖子:1136
粉蓝豆:25
经验:1155
注册时间:2006-09-26
加关注  |  发消息
17 楼    发表于2007-01-19 11:10:00举报|引用
返回顶部 | 快捷回复
 正常乳腺组织,炎症,良性肿瘤时这些免疫组化指标会发生什么样的改变呢?
0
回复

fangg 离线

帖子:1426
粉蓝豆:44
经验:1863
注册时间:2007-01-22
加关注  |  发消息
18 楼    发表于2007-02-14 13:25:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2007-02-14 13:28:00 编辑  Cytokeratin(HMW)-34BE12 应该在正常组织和导管癌中均可以表达,曾经用组织芯片进行标记过。
E-cadherin比较有用,我们常规用其鉴别导管癌和小叶癌,但确实遇到1例小叶癌阳性的。
β-catenin没有用过,以后试试。
谢谢LZ的奉献!
0
回复
signature
境随心转
回复:18 阅读:9515
共1页/18条首页上一页1下一页尾页
【免责声明】讨论内容仅作学术交流之用,不作为诊疗依据,由此而引起的法律问题作者及本站不承担任何责任。
快速回复
进入高级回复
您最多可输入10000个汉字,按 "Ctrl" + "Enter" 直接发送
搜索回复/乘电梯 ×
按内容
按会员
乘电梯
合作伙伴
友情链接